Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia.
about
Chlorpromazine versus placebo for schizophreniaChlorpromazine versus placebo for schizophreniaChlorpromazine versus placebo for schizophreniaPharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactamsRational prescription of drugs within similar therapeutic or structural class for gastrointestinal disease treatment: drug metabolism and its related interactions.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Interactions between the cytochrome P450 system and the second-generation antipsychotics.Metabolic drug interactions with new psychotropic agents.Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.Metabolic drug interactions with newer antipsychotics: a comparative review.Ciprofloxacin and Clozapine: A Potentially Fatal but Underappreciated Interaction.Clinically significant drug interactions with atypical antipsychotics.Safety issues and drug-drug interactions with commonly used quinolones.Seizure associated with clozapine: incidence, etiology, and management.Fusing Sensor Paradigms to Acquire Chemical Information: An Integrative Role for Smart Biopolymeric Hydrogels.Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.Mechanism-based inhibition of CYP1A2 by antofloxacin, an 8-NH2 derivative of levofloxacin in rats.Effect of ciprofloxacin on the pharmacokinetics of ropivacaine.Variation in the Response of Clozapine Biotransformation Pathways in Human Hepatic Microsomes to CYP1A2- and CYP3A4-selective Inhibitors.
P2860
Q24201214-B2ABA9A2-E3CF-4D05-9A8C-435DBBFFC6A3Q24245181-34F6DAF3-4B24-4C29-B284-16D85DBE07BCQ24248704-C293A5F5-2E0B-411F-AC2F-F0ECF1CB4E2CQ24631021-E56002A7-D93A-4F0C-8B82-EED8E17E01B8Q34233142-2A838414-3421-4951-888E-5D8E76F791A4Q35015993-3D8266C6-840C-436E-BBDE-72505B32C46CQ35096587-77DC8254-9E8E-4ABF-AAEC-B0E3E5DD1441Q35619640-C6792FA3-A64E-4331-8F58-11DDFC217A08Q36522045-2C5C2030-6AD4-4FC2-B4B6-F76C40952233Q36703845-72C0346C-7485-494F-8266-B3D48070A1E2Q37410806-5E0C1DE8-ABC1-4E4A-BBE2-363C6E1B17ADQ38156416-1CD8EAF0-484D-4A28-A58A-4C6F8152A94DQ38271318-7A41660B-5B66-48B7-9771-92D896739A5FQ38299304-9B285572-6500-45BD-AC3D-508053830791Q41628681-78F1BF59-CB9A-4209-9066-20C5A77BD61BQ41871344-5DB1A1CF-1EB7-4701-A40B-AD22312ED9DDQ43792574-EF18834B-A411-482E-B9C6-20B8E9C4C825Q44334614-97135A0D-5D98-40CC-831F-B9D02F737A56Q49859035-C660EEDB-787F-4580-8891-A0149C47972C
P2860
Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ciprofloxacin increases serum ...... n patients with schizophrenia.
@ast
Ciprofloxacin increases serum ...... n patients with schizophrenia.
@en
type
label
Ciprofloxacin increases serum ...... n patients with schizophrenia.
@ast
Ciprofloxacin increases serum ...... n patients with schizophrenia.
@en
prefLabel
Ciprofloxacin increases serum ...... n patients with schizophrenia.
@ast
Ciprofloxacin increases serum ...... n patients with schizophrenia.
@en
P356
P1476
Ciprofloxacin increases serum ...... n patients with schizophrenia.
@en
P2093
P J Neuvonen
P2888
P304
P356
10.1007/S002280000192
P577
2000-11-01T00:00:00Z
P6179
1045959616